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Abstract
There is evidence for participation of peripheral b-adrenoceptors in delayed liquid gastric emptying (GE) induced in rats by
dipyrone (Dp), 4-aminoantipyrine (AA), and antipyrine (At). The present study aimed to determine whether b-adrenoceptors
are involved in delayed GE induced by phenylpyrazole derivatives and the role of the prevertebral sympathetic nervous system
in this condition. Male Wistar rats weighing 220-280 g were used in the study. In the first experiment rats were intravenously
pretreated with vehicle (V), atenolol 30 mg/kg (ATE, b1-adrenergic antagonist), or butoxamine 25 mg/kg (BUT, b2-adrenergic
antagonist). In the second experiment, rats were pretreated with V or SR59230A 2 mg/kg (SRA, b3-adrenergic antagonist).
In the third experiment, rats were subjected to surgical resection of the celiac-superior mesenteric ganglion complex or to sham
surgery. The groups were intravenously treated with saline (S), 240 mmol/kg Dp, AA, or At, 15 min after pretreatment with the
antagonists or V and nine days after surgery. GE was determined 10 min later by measuring the percentage of gastric retention
(%GR) of saline labeled with phenol red 10 min after gavage. The %GR (means±SE, n=6) values indicated that BUTabolished
the effect of Dp (BUT+Dp vs V+Dp: 35.0%±5.1% vs 56.4%±2.7%) and At (BUT+At vs V+At: 33.5%±4.7% vs 52.9%
±2.6%) on GE, and significantly reduced (Po0.05) the effect of AA (BUT+AA vs V+AA: 48.0%±5.0% vs 65.2%±3.8%).
ATE, SRA, and sympathectomy did not modify the effects of treatments. These results suggest that b2-adrenoceptor activation
occurred in delayed liquid gastric emptying induced by the phenylpyrazole derivatives dipyrone, 4-aminoantipyrine, and
antipyrine. Additionally, the released neurotransmitter did not originate in the celiac-superior mesenteric ganglion complex.
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Introduction
The phenylpyrazole derivatives dipyrone, 4-aminoanti-
pyrine, and antipyrine delay liquid gastric emptying (GE) in
rats (1–3). The mechanisms involved in this process have
not been clarified and appear to be complex. A previous
study reported that peripheral b-adrenoceptor activation was
involved in this phenomenon and suggested that sympa-
thetic nervous system (SNS) nerve endings may release the
neurotransmitter norepinephrine (4).
b-adrenoceptor subtypes have been identified along the
gastrointestinal tracts of rats. b1- and b2-adrenergic recep-
tors have been detected in the mucosa and musculature of
the gastric antrum, and an indeterminate subtype has been
detected in the muscle tissue of the pylorus (5). Additionally,
elevated b3-adrenoceptor mRNA levels have been found in
the muscle fibers of the gastric fundus and moderate levels
have been found in the pylorus (6). b3-adrenoceptors parti-
cipate in the catecholamine-induced relaxation of the gastric
fundus of rats in vitro (7).
Many selective b-adrenergic antagonists are available,
but the affinity for these receptors appears to vary among
different tissues and animal species. b1-adrenoceptor anta-
gonists are used for the control of cardiovascular diseases in
humans, while b2-adrenoceptor blockade results in broncho-
spasm (8).
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In in vivo rat models with altered gastric secretion or
GE, the selective antagonists atenolol (b1-adrenergic antag-
onist) (9), butoxamine (b2-adrenergic antagonist) (10), and
SR59230A (b3-adrenergic antagonist) (9) have been used
to identify the possible b-adrenoceptor that is involved.
SNS fibers that innervate the gastrointestinal tract
mostly originate from cell bodies located in the prevertebral
ganglion chain (PVG). The arrangement of the rat PVG
differs from that of the other mammals (11). The PVG con-
sists of the celiac ganglion (CG, an intimately connected
pair), a single superior mesenteric ganglion (SMG), a single
inferior mesenteric ganglion, a pair of splanchnic ganglia in
the large splanchnic nerves, and an inter-renal ganglion
located in the intermesenteric nerve between the SMG and
inferior mesenteric ganglion. These ganglia are organized
somatotopically in such a way that the CG and SMG project
fibers to the stomach, small bowel, and proximal colon,
with a large part of the fibers that innervate the stomach
originating in the CG (12).
In the present study, we performed the following pro-
cedures to determine which b-adrenoceptors are involved in
delayed GE induced by the phenylpyrazole derivatives
dipyrone, 4-aminoantipyrine, and antipyrine, and to identify
participation of the prevertebral SNS in this process in rats:
i) blockade of b-adrenoceptors with the selective antago-
nists atenolol, butoxamine, and SR59230A, and ii) con-
comitant surgical resection of the celiac ganglion and the
superior mesenteric ganglion.
Material and Methods
Male Wistar rats weighing 220–280 g were allowed to
adapt to laboratory conditions for at least 2 weeks. The
study was approved by the Ethics Committee for Animal
Experimentation of the institution (protocol #1372, CEEA/
UNICAMP).
The rats used in the study were maintained in individual
cages. They had free access to food and water up to 24 h and
30 min before evaluation of GE between 1:00 and 4:00 pm.
Dipyrone, 4-aminoantipyrine, antipyrine, atenolol, butox-
amine, SR59230A, and dimethyl sulfoxide (DMSO) were
purchased from Sigma, USA. The solutions were prepared
at the time of use, and when indicated, were protected from
light. The doses of each drug and the method for the
preparation of the solutions for intravenous (iv) use were
established based on previous literature (9–10,13) and
tested in the laboratory in preliminary studies.
Two experiments were carried out using b-adrenergic
antagonists. The first experiment involved pretreatment with
selective b1- and b2-adrenergic antagonists, and the rats were
divided into the following groups (n=6): the ATE group,
pretreated with atenolol (ATE) dissolved in vehicle (30 mg/kg)
with a dose corresponding to 30 times the dose recom-
mended in the literature (9); the BUT group, pretreated with
butoxamine (BUT) dissolved in vehicle (25 mg/kg), corre-
sponding to approximately three times the dose indicated in
the literature (10); and the V group, pretreated with vehicle (V),
which was prepared with one part DMSO+ four parts sterile
saline (13). In the second experiment a selective b3-adrenergic
antagonist was tested. The rats were divided into the following
groups (n=6) : the SRA group, pretreated with SR59230A
(SRA) (2 mg/kg) dissolved in vehicle, corresponding to twice
the dose used for rats (9); and the V group pretreated with
vehicle, which was prepared as described in the first study.
High doses of selective b-adrenergic antagonists were
used in these pretreatments. Preliminary assessment with
these doses showed that, when care was taken to slowly
administer the drugs iv (30–40 s) in the most distal extremity
of the rat’s tail, there were no systemic repercussions
that might directly compromise GE, such as agitation and
respiratory difficulty observed in some animals with rapid
butoxamine administration. We did not include control rats
pretreated with saline. The reason for this is because a
preliminary study showed that addition of DMSO to vehicle
at the proportion used in relation to saline (1:4) did not
interfere with GE.
In the last experiment, the rats were first subjected to
surgical sympathectomy. Nine days before evaluation of
GE, these rats were sedated with 100 mg/kg ketamine
and 10 mg/kg xylazine, which were administered intraperi-
toneally. These rats were divided into two groups as
follows (n=10): rats were subjected to laparotomy with
resection of the celiac-superior mesenteric ganglion com-
plex (GLX) under a magnifying lens; and a sham group
(SH) using a technique for surgical sympathectomy of the
proximal part of the digestive tract of rats (14).
Fifteen minutes after pretreatment with the antagonists
or the vehicle, the groups were treated iv (caudal vein) with
240 mmol/kg dipyrone (Dp), 4-aminoantipyrine (AA), anti-
pyrine (At), or saline (S) (1 mL/kg) (4). The same treatment
was applied to the GLX and SH groups. GE was determined
10 min after these treatments were administered.
GE was assessed in awake animals by determining
the percentage of gastric retention (%GR) of a saline test
meal that was labeled with phenol red (60 mg/mL), in a
volume of 2 mL/100 g body weight, 10 min after admini-
stration. The test meal was administered by gavage using
a technique that was standardized in our laboratory (15),
with small modifications (16).
After this procedure, the rats were sacrificed. Those of
the GLX and SH groups were examined and those with
intraperitoneal adhesions were excluded. Ganglionectomy
was confirmed by verifying the absence of neuronal tissue
at the level of the celiac and mesenteric artery branches in
the exit of the abdominal aorta (14).
Data were analyzed by ANOVA and by the Tukey’s
test for paired comparison (a=0.05 for both tests).
Results
Figure 1 shows the results of iv pretreatment with ATE
and BUT. Rats that were pretreated with V, ATE, or BUTand
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treated with S did not show significantly different %GR
values (means±SE, n=6) among the groups (32.1%±2.6%,
28.8%±1.9%, and 24.7%±2.7%, respectively). Pretreatment
with ATE caused no significant change in the effect of Dp
(44.9%±1.3%), AA (58.2%±4.9%), or At (49.6%±4.2%)
compared with controls pretreated with V and treated with
the respective drugs (56.4%±2.7%, 65.2%±3.8%, and
52.9%±2.6%, respectively). The %GR in the ATE+Dp
group was not significantly different from that in the ATE+S
group. Pretreatment with BUT abolished the effect of Dp
(35.0%±5.1%) and At (33.5%±4.7%) compared with con-
trols pretreated with V. Pretreatment with BUT also signifi-
cantly reduced (Po 0.05), but did not abolish, the effect of
AA (48.0%±5.0%) compared with the V+AA control.
Intravenous pretreatment with SRA (Figure 2) did not
modify %GR (means±SE, n=6) in rats that were treated
with S (34.5%±3.8%) compared with controls (26.7%
±5.1%). Pretreatment with SRA also did not modify the
effect of Dp (56.5%±7.8%), AA (66.9%±3.3%), and At
(57.2%±4%) compared with rats that were pretreated with
vehicle (55.2%±1.9%, 66.8%±5%, and 54.2%±5.5%,
respectively).
Figure 3 shows the results of %GR (means±SE, n=10)
in the experiment of the effect of surgical sympathectomy.
Surgical resection of the celiac-superior mesenteric ganglion
complex did not significantly change %GR in rats that were
treated with S compared with controls (GLX+S vs SH+S:
28.2%±1.6% vs 24.9%±1.5%). Surgical resection of the
celiac-superior mesenteric ganglion complex also did not
change the effect of Dp (GLX+Dp vs SH+Dp: 46.1%±3.3%
vs 47%±3.1%), AA (GLX+AA vs SH+AA: 53.5%±3% vs
58.6%±3.8 %), and At (GLX+At vs SH+At: 47%±2.9% vs
44.1%±4%) on GE.
Discussion
In a previous study, iv pretreatment with atenolol or
butoxamine at the doses of 10 and 8 mg/kg body weight,
respectively, did not change the delay in liquid GE induced by
dipyrone, 4-aminoantipyrine, or antipyrine in rats (Vinagre AM,
personal communication). Based on this finding and evidence
of participation of b-adrenoceptors in this phenomenon (4), we
increased the doses of b1- and b2-adreneric antagonists in our
study. Additionally, previous studies have shown variation in
the selectivity and affinity of the agonists and antagonists that
are available for these b-receptors (8,17).
Figure 1. Gastric retention (%) of a saline test meal provided to
rats by gavage. The rats were pretreated (Pretreat) iv with vehicle
(V), 30 mg/kg atenolol (ATE), or 25 mg/kg butoxamine (BUT)
15 min before iv treatment (Treat) with saline (S), 240 mmol/kg
dipyrone (Dp), 4-aminoantipyrine (AA), or antipyrine (At). The test
meal was administered 10 min after treatment. Data are reported
as means±SE for 6 animals per group. *Po0.05 (Tukey’s test).
Figure 2. Gastric retention (%) of a saline test meal provided to rats
by gavage. The rats were pretreated (Pretreat) iv with vehicle (V) or
with 2 mg/kg SR59230A (SRA) 15 min before iv treatment (Treat)
with saline (S), 240 mmol/kg dipyrone (Dp), 4-aminoantipyrine (AA),
or antipyrine (At). The test meal was administered 10 min after
treatment. Data are reported as means±SE for 6 animals per
group. *Po0.05 (Tukey’s test).
Figure 3. Gastric retention (%) of a saline test meal provided to rats
by gavage. The rats were first subjected to surgical resection of the
celiac-superior mesenteric ganglion complex (GLX) or to sham
surgery (SH) and treated iv (Treat) with saline (S), 240 mmol/kg
dipyrone (Dp), 4-aminoantipyrine (AA), or antipyrine (At). The test
meal was administered 10 min after treatment. Data are reported as
means±SE for 10 animals per group. *Po0.05 (Tukey’s test).
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We found that butoxamine at a dose three times
higher than that used in a previous study (Vinagre AM,
personal communication) blocked the delay in liquid
GE induced by dipyrone and antipyrine in rats and
attenuated the effect of 4-aminoantipyrine (Figure 1).
This finding suggests that activation of b2-adrenergic
receptors occurs with these drugs. These results are
consistent with those observed in another study in which
previous adrenergic blockade with guanethidine and pre-
treatment with propranolol (nonselective b-adrenergic
antagonist) were studied (4).
In our study, atenolol (Figure 1) and SR59230A (Figure 2)
did not significantly modify the effect of phenylpyrazole
derivatives. This finding indicated unlikely activation of b1- or
b3-adrenergic receptors in delayed GE, which was induced
by dipyrone, 4-aminoantipyrine, or antipyrine. High doses of
these antagonists might compromise these interpretations
because of their potential effect on the cardiovascular
system when administered alone or in combination with
phenylpyrazole derivatives.
In two rat models, changes in gastrointestinal motility
appear to be directly related to variation in some hemo-
dynamic parameters. In the first model, consisting of
controlled bleeding, an acute decrease in arterial pressure
and central venous pressure is accompanied by increased
liquid GE (18). In the second model, consisting of a
reduction in arterial pressure and increased venous pressure
due to an aortocaval fistula, there is a delay in GE (19).
These observations suggest that distinct mechanisms may
be involved in different acute hemodynamic situations, with
repercussions on gastric motility.
Studies on rats investigating the effects of b-adrenergic
antagonists on some cardiovascular parameters have indi-
cated the following. 1) acute atenolol administration (1 mg/kg
by the peripheral intra-arterial route) significantly reduces
cardiac output, heart rate, mean arterial pressure, and
blood flow to the stomach and small bowel, increasing the
total peripheral vascular resistance (20). 2) Thirty minutes
after intraperitoneal administration of 10 mg/kg butoxa-
mine, there is no change in heart rate or mean arterial
pressure compared with basal values (21). 3) SR59230A
alone, 1 mg/kg iv, does not modify mean arterial pressure
or cardiac output in animals with liver cirrhosis (22).
Therefore, among these b-adrenergic antagonists, atenolol
has the greatest effect on the cardiovascular system. This
suggests that, in the present study, use of atenolol at a 30
times higher dose than that demonstrating an effect on the
cardiovascular system (20) may have had a greater effect
on this system.
We did not find that increasing b-blocker doses alone
modified liquid GE in rats. In the present study, the lack
of a significant difference in %GR between control
animals pretreated with vehicle or b-blockers and rats
treated with saline (Figures 1 and 2) indicates that it
is unlikely that these antagonists interfered per se with
liquid GE.
Among humans, approximately 0.4% of patients who
received dipyrone parenterally showed a significant reduction
in systolic arterial pressure as an adverse effect (23). A single
iv dose of 2 g dipyrone reduced the postoperative left
ventricular work index by 10% in patients who had heart
surgery (24). Because these changes were detected in
patients with some health problems, other factors alone or
in combination with this drug might be responsible for
these phenomena.
In our laboratory, mean arterial pressure was measured
in the left carotid artery of sedated rats (n=5–6) over 30 min
after iv administration of vehicle (saline), 240 mmol/kg
dipyrone, 4-aminoantipyrine, or antipyrine (Passafaro ACD,
personal communication). Arterial pressure remained at
similar levels to those measured initially (time 0) for up to
10 min after administration of these drugs in treated rats.
This was followed by a discrete and gradual decrease in
arterial pressure compared with controls and initial values. At
30 min after administration, the difference in arterial pressure
between the groups was not significant (Po0.08, ANOVA,
a=0.05). In the current study, we did not assess the
hemodynamic condition of the rats. However, even if the
combination of atenolol and pyrazolone derivatives substan-
tially reduced arterial pressure, this did not interfere with the
effect of treatment of the three drugs on GE (Figure 1).
Therefore, there is no evidence that pretreatment with high
doses of b-adrenergic antagonists, atenolol in particular,
compromised our results because of their effect on the
cardiovascular system.
The method of selective SNS surgery was used in our
study to determine the origin of the neurotransmitter. This
procedure is recommended for assessment of participation
of this system in phenomena observed in a target organ (25).
We simultaneously performed surgical resection of the CG
and MSG, ganglia from which efferent fibers are projected
towards the proximal part of the digestive tract of the rat
(12,14). The results of this procedure (Figure 3) suggested
that these structures were not involved in the delay in GE,
which was induced by phenylpyrazole derivatives.
There are at least three other possibilities that may
explain the origin of the neurotransmitter from the SNS.
The first possibility is that our results do not exclude
participation of the PVG in the effect of dipyrone,
4-aminoantipyrine, or antipyrine because the procedure
did not involve removal of the pair of splanchnic ganglia
that contain neurons, which together with those of the CG
and SMG, innervate the gastrointestinal tract (12). The
second possibility is that the involved neurotransmitter
may originate from fibers of the sympathetic paravertebral
ganglion chain for the distal part of the thorax. These
fibers project towards the stomach and duodenum (12).
Finally, the neurotransmitter may originate in the nora-
drenergic efferent fibers of the vagus nerve (26–28).
Although there is no strong evidence of occurrence of
these fibers, this possibility is supported by the fact that
subdiaphragmatic vagotomy abolishes or reduces the
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effect of studied drugs (1–3). However, this possibility is
not as likely if we consider that vagotomy also results in
the incision of capsaicin-sensitive afferent fibers, which
are involved in the effect of dipyrone, 4-aminoantipyrine,
or antipyrine on GE in rats (16).
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